Final

Urinary Incontinence

Description of a weakly supervised machine learning approach for extracting treatment-related side effects (Urinary Incontinence) following prostate cancer therapy from multiple types of free-text clinical narratives, including progress notes, discharge summaries, history and physical notes. Prostatectomy surgery and radiation therapy are our treatments of interest for prostate cancer.

Final

Warfarin dose/response

This algorithm identifies patients who have a stable within-range INR (assuming a target INR of 2-3) over at least a three week period and correlates with their warfarin weekly dose.  It is used to identify pharmacogenetics behind warfarin stable dose.

Final

White Blood Cell Indices

Genetic variation that predicts white blood count (WBC) and it differential, a marker of the health of the immune system.

WBC is unique among the identified inflammatory predictors of chronic disease in that it has been routinely measured in healthy patients in an unbiased way for the duration of the electronic medical record data. 

View Phenotyping Groups: 
Final

Pages